Published in Methods Enzymol on January 01, 1974
Amplitude, kinetics, and reversibility of a light-induced decrease in guanosine 3',5'-cyclic monophosphate in frog photoreceptor membranes. J Gen Physiol (1979) 2.15
Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants. Proc Natl Acad Sci U S A (1996) 0.99
Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells. Invest Ophthalmol Vis Sci (2007) 0.87
Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet (1998) 3.78
Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase. Proc Natl Acad Sci U S A (1975) 3.50
Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet (1999) 3.02
Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J (1999) 2.75
Activation of skeletal muscle phosphorylase kinase by adenosine triphosphate and adenosine 3',5'-monophosphate. J Biol Chem (1968) 2.03
Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers. Antimicrob Agents Chemother (1986) 1.60
Evolution of phosphofructokinase--gene duplication and creation of new effector sites. Nature (1984) 1.52
Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr (2002) 1.45
Thumb reconstruction in a bilateral upper extremity amputee: an alternative to the Krukenburg procedure. J Hand Surg Am (1999) 1.39
Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol (1998) 1.36
Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung. J Pharmacol Exp Ther (1997) 1.30
Rabbit liver phosphofructokinase. Comparison of some properties with those of muscle phosphofructokinase. J Biol Chem (1971) 1.30
Clinical and radiographic spectrum of septic pulmonary embolism. Arch Dis Child (2002) 1.25
Duration of enterovirus shedding in stool. J Microbiol Immunol Infect (2001) 1.24
Cloning, sequencing, and expression of pyrophosphate-dependent phosphofructokinase from Propionibacterium freudenreichii. J Biol Chem (1991) 1.20
Isozymes of rabbit phosphofructokinase. Electrophoretic and immunochemical studies. J Biol Chem (1973) 1.20
Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan. Scand J Infect Dis (1998) 1.20
Allosteric regulatory properties of muscle phosphofructokinase. Mol Cell Biochem (1983) 1.19
Binding of metabolites by phosphofructokinase. Biochemistry (1967) 1.17
Interaction of inhibitors with muscle phosphofructokinase. J Biol Chem (1975) 1.06
Lactobacillus kunkeei sp. nov.: a spoilage organism associated with grape juice fermentations. J Appl Microbiol (1998) 1.04
Surgical implications of pseudomonas aeruginosa necrotizing fasciitis in a child with acute lymphoblastic leukemia. J Pediatr Surg (2001) 1.03
Isolation and characterization of phosphofructokinase C from rabbit brain. J Biol Chem (1985) 1.03
Association of COL11A2 polymorphism with susceptibility to Kawasaki disease and development of coronary artery lesions. Int J Immunogenet (2010) 1.02
Identification of allosteric sites in rabbit phosphofructo-1-kinase. Biochemistry (1999) 1.02
Phosphofructokinase from rabbit skeletal muscle. Methods Enzymol (1975) 1.02
Rabbit brain phosphofructokinase. Comparison of regulatory properties with those of other phosphofructokinase isozymes. J Biol Chem (1974) 1.01
Creatinine XII: comparison of assays of low serum creatinine levels using high-performance liquid chromatography and two picrate methods. J Pharm Sci (1983) 1.00
Puromycin: a potent metabolic effect independent of protein synthesis. Biochem Biophys Res Commun (1966) 0.99
Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Eng (2007) 0.99
Activation of skeletal muscle phosphorylase. Pharmacol Rev (1966) 0.99
Kawasaki disease presenting as cervical lymphadenitis or deep neck infection. Otolaryngol Head Neck Surg (2001) 0.99
Catatonic features: differential diagnosis and treatments at an emergency unit. Psychiatry Clin Neurosci (1999) 0.99
Analysis of rat vitamin D-dependent calbindin-D28k gene expression. J Biol Chem (1988) 0.98
The mechanism of ATP inhibition of wild type and mutant phosphofructo-1-kinase from Escherichia coli. J Biol Chem (1992) 0.97
Binding of hexose bisphosphates to muscle phosphofructokinase. Biochemistry (1983) 0.97
Thymus adenylate cyclase activity during murine leukemogenesis. Science (1974) 0.97
Noninvasive glucose monitoring in vivo with an optical heterodyne polarimeter. Appl Opt (1998) 0.96
Subcutaneous adipose tissue distribution in adolescent girls of four ethnic groups. Int J Obes Relat Metab Disord (1995) 0.96
MRI in a case of adult-onset citrullinemia. Neuroradiology (2001) 0.96
Exogenous ATP enhances calcium influx in intact thymocytes. J Immunol (1985) 0.95
Hypoxia inhibits nitric oxide synthesis in isolated rabbit lung. Am J Physiol (1997) 0.95
Transarterial embolisation of complex cavernous sinus dural arteriovenous fistulae with low-concentration cyanoacrylate. Neuroradiology (2000) 0.95
Reactivity of the sulfhydryl groups of muscle phosphofructokinase. Biochemistry (1968) 0.95
Methicillin-resistant Staphylococcus aureus bacteraemia in neonatal intensive care units: an analysis of 90 episodes. Acta Paediatr (2004) 0.95
Posterior cranial fossa arteriovenous fistula with presenting as caroticocavernous fistula. Neuroradiology (2001) 0.95
Inorganic pyrophosphate: fructose-6-phosphate 1-phosphotransferase of the potato tuber is related to the major ATP-dependent phosphofructokinase of E. coli. Biochem Biophys Res Commun (1988) 0.95
Properties of a phosphodiesterase with high affinity for adenosine 3',5'-cyclic phosphate. Biochemistry (1971) 0.94
Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS). Vaccine (1992) 0.93
Prospective and retrospective longitudinal studies of the growth, maturation, and fitness of Polish youth active in sport. Int J Sports Med (1997) 0.93
Distribution of phosphofructokinase isozymes in rabbit, mouse, guinea pig and rat. Comp Biochem Physiol B (1975) 0.93
Inhibition of muscle pyruvate kinase by creatine phosphate. J Biol Chem (1973) 0.93
Inhibition of the lectin-induced mitogenic response of thymocytes by glycolipids. Cancer Res (1979) 0.92
Isozyme composition and phosphorylation of brain phosphofructokinase. Arch Biochem Biophys (1984) 0.92
Effect of emitted bioenergy on biochemical functions of cells. Am J Chin Med (1991) 0.92
Activation of muscle fructose 1,6-diphosphatase by creatine phosphate and citrate. J Biol Chem (1973) 0.92
Topology of feather melanocyte progenitor niche allows complex pigment patterns to emerge. Science (2013) 0.92
Relationship between serotypes and genotypes based on the hypervariable region of the S1 gene of infectious bronchitis virus. Arch Virol (2000) 0.91
Scoring system for empyema thoracis and help in management. Indian J Pediatr (2005) 0.91
Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model. Ann Emerg Med (1988) 0.91
Caffeine inhibits the viability and osteogenic differentiation of rat bone marrow-derived mesenchymal stromal cells. Br J Pharmacol (2010) 0.91
Phosphofructokinase in the rat nervous system: regional differences in activity and characteristics of axonal transport. J Neurosci Res (1988) 0.91
Effect of cyclic 3':5'-AMP derivatives prostaglandins and related agents on human chorionic gonadotropin secretion in human malignant trophoblast in culture. In Vitro (1977) 0.91
Bacterial priming increases lung injury in gram-negative sepsis. Am J Respir Crit Care Med (1998) 0.90
Identification of basic residues involved in substrate binding and catalysis by pyrophosphate-dependent phosphofructokinase from Propionibacterium freudenreichii. J Biol Chem (1994) 0.90
Differential expression of arginase and iNOS in the lung in sepsis. Exp Lung Res (1998) 0.90
The pyrophosphate-dependent phosphofructokinase of the protist, Trichomonas vaginalis, and the evolutionary relationships of protist phosphofructokinases. J Mol Evol (1998) 0.90
Loop-mediated isothermal amplification method for rapid detection of Vibrio alginolyticus, the causative agent of vibriosis in mariculture fish. Lett Appl Microbiol (2010) 0.89
Combined benzoporphyrin derivative monoacid ring photodynamic therapy and pulsed dye laser for port wine stain birthmarks. Photodiagnosis Photodyn Ther (2009) 0.89
Allosteric properties of muscle phosphofructokinase. I. Binding of magnesium adenosine triphosphate to the inhibitory site. Biochemistry (1969) 0.89
Contrasting response of lung parenchymal cells to instilled TNF alpha and IFN gamma: the inducibility of specific cell ICAM-1 in vivo. Am J Respir Cell Mol Biol (1996) 0.88
Oral acyclovir prophylaxis of varicella after intimate contact. Pediatr Infect Dis J (1997) 0.87
Blunt abdominal aortic transection in a child: case report. J Trauma (1996) 0.87
The primordial high energy compound: ATP or inorganic pyrophosphate? J Biol Chem (2000) 0.87
Properties of phospho and dephospho forms of muscle phosphofructokinase. J Biol Chem (1982) 0.87
Obesity concerns, weight satisfaction and characteristics of female dieters: a study on female Taiwanese college students. J Am Coll Nutr (1999) 0.87
Cloning and sequencing a putative pyrophosphate-dependent phosphofructokinase gene from Entamoeba histolytica. Biochim Biophys Acta (1995) 0.87
Traumatic retropharyngeal hematoma: case report. J Trauma (1999) 0.87
The two phosphofructokinase gene products of Entamoeba histolytica. J Biol Chem (2001) 0.86
Energy metabolism in thymic lymphocytes of normal and leukemia AKR mice. Cancer Res (1978) 0.86
Expression, characterization, and crystallization of the pyrophosphate-dependent phosphofructo-1-kinase of Borrelia burgdorferi. Arch Biochem Biophys (1999) 0.86
Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis. J Appl Physiol (1985) (1997) 0.86
Protection of perfused lung from oxidant injury by inhibitors of anion exchange. Am J Physiol (1997) 0.86
Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase: revised amino acid sequence, site-directed mutagenesis, and microenvironment characteristics of cysteines 365 and 458. Biochemistry (1995) 0.86
Cranial nerve palsies and cerebral infarction in a young infant with meningococcal meningitis. Scand J Infect Dis (1995) 0.85
Lung epithelial cell-released nitric oxide protects against PMN-mediated cell injury. Am J Physiol (1996) 0.85
Transcriptional regulation and chromosomal assignment of the mammalian calbindin-D28k gene. Mol Endocrinol (1989) 0.85
[The biological effect of sodium butyrate (NaBT) on SGC-7901 cells]. Shi Yan Sheng Wu Xue Bao (1989) 0.85
Aurintricarboxylic acid is a potent inhibitor of phosphofructokinase. Biochem J (1989) 0.85
Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. I. Physiology and biochemistry. J Appl Physiol (1985) (1997) 0.85
Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems. J Pharm Sci (1983) 0.85
Gastric teratoma in infancy: report of a case and review of world literature. Ann Surg (1973) 0.85
Unilateral pulmonary edema during general anesthesia--report of two cases. Acta Anaesthesiol Sin (1997) 0.85
Deep neck infections in children. J Microbiol Immunol Infect (2001) 0.84
Preliminary trials of inactivated vaccine against haemorrhagic fever with renal syndrome. Lancet (1991) 0.84
Identification of amino acids modified by the bifunctional affinity label 5'-(p-(fluorosulfonyl)benzoyl)-8-azidoadenosine in the reduced coenzyme regulatory site of bovine liver glutamate dehydrogenase. Biochemistry (1992) 0.84
Diagnosis of respiratory tract viruses in 24 h by immunofluorescent staining of shell vial cultures containing Madin-Darby Canine Kidney (MDCK) cells. J Virol Methods (1999) 0.84
Constitutive expression of interleukin-18 and interleukin-18 receptor mRNA in tumour derived human B-cell lines. Clin Exp Immunol (2004) 0.84
Midpoint back-extrapolation method for the rapid estimation of drugs' volume of distribution and dosage adjustment exhibiting multicompartmental characteristics. Int J Clin Pharmacol Ther Toxicol (1980) 0.84